These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
135 related items for PubMed ID: 8745663
1. [Comparative effects of cibenzoline and hydroquinidine in the prevention of auricular fibrillation. A randomized double-blind study]. Touboul P, Brembilla-Perrot B, Scheck F, Gabriel A, Lardoux H, Marchand X, Levy S. Ann Cardiol Angeiol (Paris); 1995 Nov; 44(9):525-31. PubMed ID: 8745663 [Abstract] [Full Text] [Related]
2. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study]. Lardoux H, Maison Blanche P, Marchand X, Canler A, Rouesnel P, Bleinc D, Péraudeau P, Scheck F. Ann Cardiol Angeiol (Paris); 1996 Oct; 45(8):469-79. PubMed ID: 8952741 [Abstract] [Full Text] [Related]
3. [Comparative study of cibenzoline and flecainide by oral route for preventing recurrence of paroxysmal atrial tachyarrhythmias]. Maison-Blanche P, Brembilla-Perrot B, Fauchier JP, Babuty D, Garnier LF, Rouesnel P, Breuillac JC, Funck F, Scheck F, Peraudeau P, Medvedowsky JL. Ann Cardiol Angeiol (Paris); 1997 Feb; 46(2):109-16. PubMed ID: 9137677 [Abstract] [Full Text] [Related]
4. [Long-term prevention of the recurrence of auricular fibrillation using cibenzoline. Multicenter study apropos of 89 case reports]. Frances Y, Luccioni R, Delaage M, Donnarel G, Medvedowsky JL, Quiret JC. Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():99-103. PubMed ID: 3938266 [Abstract] [Full Text] [Related]
5. Cibenzoline versus flecainide in the prevention of paroxysmal atrial arrhythmias: a double-blind randomized study. Babuty D, D'Hautefeuille B, Scheck F, Mycinsky C, Pruvost P, Peraudeau P. J Clin Pharmacol; 1995 May; 35(5):471-7. PubMed ID: 7657846 [Abstract] [Full Text] [Related]
9. Widening of the excitable gap during pharmacological cardioversion of atrial fibrillation in the goat: effects of cibenzoline, hydroquinidine, flecainide, and d-sotalol. Wijffels MC, Dorland R, Mast F, Allessie MA. Circulation; 2000 Jul 11; 102(2):260-7. PubMed ID: 10889140 [Abstract] [Full Text] [Related]
15. Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine. Hohnloser SH, van de Loo A, Baedeker F. J Am Coll Cardiol; 1995 Oct 11; 26(4):852-8. PubMed ID: 7560608 [Abstract] [Full Text] [Related]
16. Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial. Fetsch T, Bauer P, Engberding R, Koch HP, Lukl J, Meinertz T, Oeff M, Seipel L, Trappe HJ, Treese N, Breithardt G, Prevention of Atrial Fibrillation after Cardioversion Investigators. Eur Heart J; 2004 Aug 11; 25(16):1385-94. PubMed ID: 15302102 [Abstract] [Full Text] [Related]
19. [Efficacy of cibenzoline in the termination and long-term prevention of paroxysmal atrial fibrillation: analysis based on the time of onset]. Komatsu T, Nakamura S, Kimura M, Owada S, Saito E, Kobayashi T, Okumura K. J Cardiol; 2001 Feb 11; 37(2):75-82. PubMed ID: 11255698 [Abstract] [Full Text] [Related]
20. Comparative efficacy and safety of oral cibenzoline and quinidine in ventricular arrhythmias: a randomized crossover study. Wasty N, Saksena S, Barr MJ. Am Heart J; 1985 Dec 11; 110(6):1181-8. PubMed ID: 4072875 [Abstract] [Full Text] [Related] Page: [Next] [New Search]